MY ACCOUNT | NEWSLETTER |

Equine genital leptospirosis: Evidence of an important silent chronic reproductive syndrome


Leptospirosis may be associated with important syndromes in equines, including those of reproductive age.  

Recently, a research team demonstrated a reproductive syndrome of leptospirosis in ruminants (Bovine Genital Leptospirosis - BGL), that presents its own agent, particular diagnostic methods, and specific treatment and prevention, requiring special attention. Researchers realized that the genital syndrome of leptospirosis may not be exclusive to ruminants and may also affect horses.  

The aim of the present study is to gather the available data on leptospirosis in equine reproduction and propose a new genital leptospirosis syndrome in horses, which we have named Equine Genital Leptospirosis (EGL).  

The main agent is most probably serovar Bratislava (serogroup Australis), whose role has been increasingly recognized in the etiology of infection, presenting a worldwide distribution. The most probable relevant transmission route in the EGL context is the sexual transmission. Subfertility, estrus repetition, and, less commonly, late-term abortions are the most common effects.  

Serology may not be adequate to diagnose this chronic silent reproductive leptospiral infection. As most studies regarding equine leptospirosis investigate urinary samples, EGL is vastly underdiagnosed, and the disease is little studied and underestimated. Therefore, PCR, particularly from cervicovaginal mucus (CVM) and uterine fragments, turns out to be a rapid and definitive diagnosis choice.  

In order to mitigate the effects of the disease in equines, triad antibiotic therapy, vaccination and environmental management are essential. Adequate recognition of the particularities of this syndrome may help to highlight its occurrence and contribute to a broader understanding of its clinical manifestations, use of a correct diagnosis and development of novel approaches for its control. 

Equine genital leptospirosis: Evidence of an important silent chronic reproductive syndrome.” Maria Isabel Nogueira Di Azevedo, et al. Theriogenology. 2022 Aug 28; 192:81-88. doi: 10.1016/j.theriogenology.2022.08.029. 

Like0
Dislike0
  • Please enter a comment


Name *
Email address *
Comment *


* Required fields

Information on the processing of your personal data
We inform you that, in compliance with the provisions of current national and European regulations for the Protection of Personal Data and Services of the Information Society and Electronic Commerce, by sending us this form you are expressly giving your consent to Grupo Asís Biomedia , SL, (hereinafter, "ASIS GROUP") so that, as the person in charge, it may process your personal data in order to respond to your request for contact and information by electronic means.

Likewise, when you expressly consent, we will process your personal data to send you specialized information, newsletters, offers and exclusive promotions from GRUPO ASIS and related companies.

For the aforementioned purpose, GRUPO ASIS may transfer your data to other companies linked to GRUPO ASIS or to third party service providers for the management of electronic communications and other security services, even in cases where they are outside of the European Union, provided that they legally guarantee the adequate level of protection required by European regulations.

At any time you can withdraw the consent given and exercise the rights of access, rectification, deletion, portability of your data and limitation or opposition to its treatment by contacting GRUPO ASIS by sending an email to protecciondatos @ grupoasis.com, or by written communication to address at Centro Empresarial El Trovador, 8th floor, office I, Plaza Antonio Beltrán Martínez 1, 50002, Zaragoza (Spain), indicating in either case the Ref. Personal data and the right you exercise, as well as attaching a copy of your ID or replacement identification document.


I have read and accept the treatment of my data according to the informed purpose and according Legal notes and the Privacy Policy
I wish to receive commercial information from GRUPO ASIS and related companies



More news

Advancing the 3Rs: innovation, implementation, ethics and society

Like0
Dislike0

Automated Knowledge-Based Radiation Treatment Planning in Canine and Feline Nasal Tumors

Like0
Dislike0

Does Lung Function Imaging Modality Have a Dosimetric Impact On Functional Avoidance Treatment Planning: Assessment Using Prospective Clinical Trial Data

Like0
Dislike0

One Committed and Caring NC State Veterinary Student, So Many Choices

Like1
Dislike0

Dentalis Earns 5 VOHC® Seals, Positioning for Global Expansion in Animal Health

Like0
Dislike0

Newsletter

 
 

News of interest

EVENTS

Copyright © 2025 - All Rights Reserved
ISSN 2768-198X

Top